Counterweight Ventures LLC Purchases 578 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Counterweight Ventures LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,386 shares of the healthcare conglomerate’s stock after buying an additional 578 shares during the period. UnitedHealth Group accounts for 2.2% of Counterweight Ventures LLC’s portfolio, making the stock its 19th biggest position. Counterweight Ventures LLC’s holdings in UnitedHealth Group were worth $3,149,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in UNH. China Universal Asset Management Co. Ltd. raised its holdings in UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after acquiring an additional 1,857 shares during the last quarter. Quent Capital LLC lifted its holdings in shares of UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares in the last quarter. Ossiam increased its holdings in UnitedHealth Group by 1.9% in the 1st quarter. Ossiam now owns 120,403 shares of the healthcare conglomerate’s stock worth $59,563,000 after buying an additional 2,199 shares in the last quarter. Crewe Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $1,015,000. Finally, Payden & Rygel Investment Group bought a new position in UnitedHealth Group during the first quarter valued at approximately $15,029,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Truist Financial reaffirmed a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Finally, HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $589.65 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $542.64 billion, a price-to-earnings ratio of 38.41, a P/E/G ratio of 1.74 and a beta of 0.58. The firm has a fifty day moving average price of $582.75 and a 200 day moving average price of $550.66. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the business earned $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.